| ISA-2011B |
1395347-24-6 |
1395347-24-6 |
| SUVN-G3031 |
SUVN-G3031 |
1394808-82-2 |
| VU 0463271 |
VU 0463271 |
1391737-01-1 |
| Umibecestat |
Umibecestat |
1387560-01-1 |
| KRN2 |
1390654-28-0 |
1390654-28-0 |
| sodium(R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-ylphosphate |
FOBREPODACIN |
1384984-31-9 |
| T2-aminoalcohol hydrochloride |
化合物T2AA |
1380782-27-3 |
| CCR2 antagonist 3 |
CCR2 ANTAGONIST 3 |
1380100-86-6 |
| XD14 |
CS-2672 |
1370888-71-3 |
| CG-806 |
1370466-81-1 |
1370466-81-1 |
| 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoicacid |
化合物PF-05221304 |
1370448-25-1 |
| 2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]- |
2,4-Imidazolidinedione, 5-[[4-[4-hydroxy-3-(1-methylethyl)phenoxy]-3,5-diiodophenyl]methyl]- |
1370363-74-8 |
| N-{2-[4-(but-2-yn-1-yloxy)benzenesulfonyl]-1-[4-(methanesulfonamidomethyl)phenyl]ethyl}-N-hydroxyformamide |
KP-457 |
1365803-52-6 |
| N-(4-carboxybenzyl)-N,N-diMethyl-2,3-bis(oleoyloxy)propan-1-aMiniuM |
N-(4-CARBOXYBENZYL)-N,N-DIMETHYL-2,3-BIS(OLEOYLOXY)PROPAN-1-AMINIUM;DOBAQ |
1360461-69-3 |
| AVL 292 benzenesulfonate |
1360053-81-1 |
1360053-81-1 |
| 1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1357349-91-7 |
| 2-methoxy-5-methyl-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline |
2-methoxy-5-methyl-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline |
1356963-01-3 |
| 7,8-Dihydro-2,3-bis(4-methylphenyl)pyrido[2,3-b]pyrazine-5(6H)-heptanoic acid |
7,8-二氢-2,3-二(4-甲基苯基)吡啶并[2,3-B]吡嗪-5(6H)-庚酸 |
1356331-63-9 |
| UDP-GlcNTFA.2Na |
UDP-GLCNTFA.2NA |
1355005-47-8 |
| WEHI-345 (analog) |
1354825-62-9 |
1354825-62-9 |
QQ
微信
